As of 2026-01-08, the Relative Valuation of Protagonist Therapeutics Inc (PTGX) is 30.54 USD. This relative valuation is based on P/E multiples. With the latest stock price at 82.34 USD, the upside of Protagonist Therapeutics Inc based on Relative Valuation is -62.9%.
The range of the Relative Valuation is 14.79 - 53.42 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 24.8x | 22.5x |
| Forward P/E multiples | 22.6x - 33.8x | 28.2x |
| Fair Price | 14.79 - 53.42 | 30.54 |
| Upside | -82.0% - -35.1% | -62.9% |
| Date | P/E |
| 2026-01-02 | 118.72 |
| 2025-12-31 | 118.94 |
| 2025-12-30 | 118.83 |
| 2025-12-29 | 119.75 |
| 2025-12-26 | 120.90 |
| 2025-12-24 | 120.98 |
| 2025-12-23 | 120.83 |
| 2025-12-22 | 119.04 |
| 2025-12-19 | 117.18 |
| 2025-12-18 | 116.83 |
| 2025-12-17 | 121.67 |
| 2025-12-16 | 124.66 |
| 2025-12-15 | 129.09 |
| 2025-12-12 | 129.85 |
| 2025-12-11 | 125.63 |
| 2025-12-10 | 124.44 |
| 2025-12-09 | 120.60 |
| 2025-12-08 | 122.90 |
| 2025-12-05 | 122.09 |
| 2025-12-04 | 118.93 |
| 2025-12-03 | 117.21 |
| 2025-12-02 | 115.28 |
| 2025-12-01 | 116.63 |
| 2025-11-28 | 122.56 |
| 2025-11-26 | 122.66 |
| 2025-11-25 | 122.37 |
| 2025-11-24 | 119.42 |
| 2025-11-21 | 116.30 |
| 2025-11-20 | 114.67 |
| 2025-11-19 | 115.93 |
| 2025-11-18 | 114.92 |
| 2025-11-17 | 115.44 |
| 2025-11-14 | 115.22 |
| 2025-11-13 | 113.36 |
| 2025-11-12 | 115.55 |
| 2025-11-11 | 116.52 |
| 2025-11-10 | 113.34 |
| 2025-11-07 | 108.32 |
| 2025-11-06 | 108.65 |
| 2025-11-05 | 106.06 |
| 2025-11-04 | 104.18 |
| 2025-11-03 | 103.43 |
| 2025-10-31 | 107.07 |
| 2025-10-30 | 106.02 |
| 2025-10-29 | 104.44 |
| 2025-10-28 | 106.92 |
| 2025-10-27 | 102.48 |
| 2025-10-24 | 101.95 |
| 2025-10-23 | 100.75 |
| 2025-10-22 | 100.09 |